Systech Launches New All-in-One Pharma Packaging and Serialization Stations
New integrated solutions help pharmaceutical manufacturers and CDMOs increase automation, improve efficiency, and streamline packaging operations
Home > Events/News
Stay ahead of the curve with our timely news and events for critical updates on the latest industry trends and technologies.
Join us and other industry experts through our comprehensive events calendar.
Stay at the forefront of latest industry updates and trends with our industry articles.
Check out the announcements section for our company updates and developments
October 6-8, 2026 | Fiera Milano, Italy
Stand 9C82, Zone Machinery & Equipment
October 18–21, 2026 | McCormick Place | Chicago, IL
Booth W-22048 | Healthcare Packaging Pavilion
November 2-5, 2026 | Boston, Massachusetts
Get access to our latest webinar recording: “DSCSA compliance: Key insights and next steps to streamline your journey” and explore a variety of topics from the future of traceability to anti-counterfeiting and more…
Systech’s Joe Lipari describes how serialization planning, data visibility and partner connectivity can help biopharma companies prepare complex therapies for commercial scale.
Systech has launched TraceIQ, a new traceability platform combining pharmaceutical compliance capabilities with AI-assisted analytics to help manufacturers prevent disruptions and improve operational decision-making.
Sreedhar Patnala, GM at Systech speaks about the growing problem of drug counterfeit and diversion and how Systech is addressing it with its innovative solutions.
Sreedhar Patnala, GM at Systech, looks at the impact of AI and Machine Learning on the future of the pharmaceutical supply chain.
As the landscape shifts, pharmaceutical companies, distributors and other key stakeholders must remain agile and prepared to adapt to ongoing changes to ensure compliance and safeguard the drug supply chain.
Sreedhar Patnala, GM at Systech discusses the risks that pharma supply chains face and how serialization can help combat those.
Sreedhar Patnala, GM at Systech speaks about the importance of technology in leveraging product protection and brand identity.
Sreedhar Patnala highlights the significance of product protection and the steps Systech is taking to provide solutions for its customers.
Exception management and traceability tips to ease compliance with the FDA’s Drug Supply Chain Security Act from Joe Lipari of Systech.
How proactive traceability programs to future-proof supply chain by Jim Waters, Senior Director of Marketing of Systech.
In the second part of his video interview with Pharma Commerce, Joe Lipari, director of product management comments on what the repercussions are for failing to comply with the DSCSA.
In the first part of this video interview with Pharma Commerce, Joe Lipari from Systech describes the latest state of DSCSA implementation guidelines.
In this article we discuss the repercussions of counterfeit drug epidemic on patients and what pharma companies must to combat the problem.
Cosmetics Design spoke to Systech on how counterfeit beauty products have become an increasingly rising threat that needs to be tackled immediately.
Cosmetics Design spoke to Systech on how beauty brands can fight the war on counterfeit cosmetics to protect themselves and their customers in this 2-part series.
Stephan von Schilcher takes us through how counterfeiters impact the personal care industry and how Systech offers several brand protection solutions to address that.
Medical plastics news talks to Sreedhar Patnala, General Manager at Systech about mapping the counterfeit and diversion epidemic in the pharma and medical device industries.
In the fast-paced world of healthcare, ensuring the uninterrupted flow of critical medical devices and products is paramount. Stephan von Schilcher explains how to overcome these challenges by utilizing tracking and tracing technology.
Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability to combat drug counterfeiting.
Stephan von Schilcher, global strategic account manager at Systech explores mapping the counterfeit and diversion epidemic in the pharmaceutical industry.
Here are the takeaways from a recent webinar hosted by Systech with IDC analysts to address the challenges presented by the pharmaceutical supply chain.
Dave DeJean explains how adopting traceability technologies provides more than just enhanced safety. Manufacturers gain valuable data that helps optimize supply chain operations and mitigate risk.
In a recent interview, Sreedhar Patnala discusses the impact some of the most common supply chain visibility challenges have on sustainability.
A recent interview with Sreedhar Patnala to shares his insights on the evolution of the counterfeit drug trade, best practices in pharmaceutical traceability and the holistic approach to tackle this.
David DeJean – Vice President of Global Strategic Accounts, Systech speaks about the requirements of DSCSA and how collaboration is crucial for identifying and addressing gaps.
Pharmaceutical Market Europe spoke to Remi Turbet Delof from Systech about his work with customers to help them navigate the complex world of serialisation
Systech’s Dave DeJean writes about the various challenges faced by the pharmaceutical supply chain and how embracing technological innovation and collaborative strategies is the way forward for improving distribution efficiency and security.
Insights from Girish Juneja, Chief Digital Officer at Dover Corporation. This video podcast highlights the evolution of supply chains from being relatively stable to facing significant disruptions due to various crises, including healthcare, geopolitical issues, and inflation.
Rising numbers of counterfeit drugs are entering pharmaceutical supply chains, necessitating advanced track-and-trace systems. With accessibility compromised, a fragile and disrupted pharma landscape poses further threats to emerging counterfeit medications’ potential impact on patient health and safety.
What can the medical devices industry learn from the existing strategies of combating diversion and counterfeiting in the pharmaceutical industry? Dave DeJean from Systech gives interesting insights.
Joe Lipari gives an update on the DSCSA stabilization period and what to have in place for November 2024. If you didn’t get a system in place or processes to meet the requirements, you’re not in the stabilization period. One should already be working the kinks out.
The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting and grey market trading
Remi Turbet Delof discerns pharmaceutical packaging trends. Digital fingerprinting and serialization can help with non-replicable solutions that can work with existing packaging and allow the product to be tracked and traced along the supply chain, with companies like Systech employing AI and machine learning to detect inconsistencies.
Remi Turbet Dulof provides his expert insight on key trends that significantly influence the future of pharmaceutical packaging from the recent Pharmapack show held in Paris, France.
Dave DeJean provides his expert insight on lessons he’s learned from his plethora of time in the industry, along with an outlook on where the pharma supply chain stands in adhering to the Drug Supply Chain Security Act (DSCSA).
David DeJean, VP of global strategic accounts at Systech, explains how regulation, serialization, traceability, and developing technologies can help tackle counterfeit products in the pharmaceutical industry.
The FDA’s grace period of November 2024 doesn’t change the implementation deadline. It’s just extra time for the industry to dial-in processes already in place.
“The pharmaceutical supply chain is an excellent place to look for guidance on best practices to enhance supply chain efficiency,” writes Girish Juneja in a recent article in Supply & Demand Chain Executive.
“If data and product don’t flow seamlessly across the pharma supply chain, massive rework requirements will boomerang back to manufacturers, demanding packaging operations scale rework capabilities to unprecedented levels,” writes…
As the DSCSA deadline looms, is your data in order? “All stakeholders in the drug supply chain must adopt robust data management systems and processes to ensure the accurate and…
Worldwide, medical device fraud runs rampant. Steve Tallant examines this growing threat in a recent Viewpoint column featured in Securing Industry. By implementing a sophisticated tracking system, medical device manufacturers…
“While the DSCSA has already brought numerous positive changes to the supply chain, even a minor hiccup could throw the entire system off-kilter,” writes @Steve Tallant in an article featured…
The services will include compliance testing, a readiness GAP review and master organizational validation.
“Greater transparency among trading partners opens the door to better communication, better collaboration, and, ultimately, better decision-making,” writes Victoria Kickham in her feature for DC Velocity. Victoria spoke with Systech’s…
New integrated solutions help pharmaceutical manufacturers and CDMOs increase automation, improve efficiency, and streamline packaging operations
Systech TraceIQ™ combines enterprise traceability, operational intelligence and AI-assisted investigations to help manufacturers prevent disruptions, accelerate exception resolution and improve product availability
Systech, the global leader in pharmaceutical serialization, traceability and packaging intelligence, today announced the availability of its fully integrated track-and-trace hardware portfolio to the US market.